Mizuho Markets Americas LLC purchased 166,262 shares of
L3Harris Technologies, significantly increasing their stake in the company. Despite periods of underperformance compared to competitors,
L3Harris reported strong results in Q3 2024 and increased its guidance for the year. The stock continues to attract noteworthy attention from other market players, with
Aerospace/Defense giant
L3Harris Technologies nearing a 2-year high. Major indexes show fluctuations in the trading of
L3Harris shares, with both increases and decreases being observed. There is significant institutional ownership in the company, with institutions holding 86% of
L3Harris. Various investment advisory groups have purchased shares, indicating a solid interest in the biotech firm. A strategic partnership with
Palantir was also announced, highlighting a collaboration strategy to boost business further. Additionally,
L3Harris' Q3 earnings surpassed estimates, and revenues increased Y/Y. However, despite the positive factors, concerns have been raised about the company's financial health and whether its rising stock is indicative of weak fundamentals.
L3harris Technologies LHX News Analytics from Mon, 17 Jun 2024 07:00:00 GMT to Sat, 16 Nov 2024 14:39:41 GMT -
Rating 8
- Innovation 7
- Information 6
- Rumor -2
